Privacy Policy

INTRODUCTION 

1. Introduction

Owlstone Medical ® Limited (referred to as “OML”, “We, “Our” or “Us”), is committed to protecting the privacy and security of your personal information. We take care to protect the privacy of all individuals who interact with us as well as those whose personal data has been shared with us by third parties.

We have therefore developed this privacy notice to inform you of the data we collect, what we do with your information, what we do to keep it secure as well as the rights and choices you have over your personal information. It applies to our clinical trial volunteers (or prospective clinical trial volunteers), our clients and their staff, our suppliers/partners and their staff, investors, health care professionals, professional advisors, researchers, physicians, prospective employees and all other users or parties that otherwise interact with us or visit our website.

We may provide additional privacy notices to you in certain specific circumstances at the time we collect your data. For example, we provide additional privacy information to clinical trial or other research participants to describe our privacy practices in connection with conducting research studies, and we also provide additional privacy information to our employees and workers, or prospective job applicants when they apply for a job with us. Such notices will govern how we process the information you provide at that time.

This notice does not cover our processing undertaken as part of OMED Health® or through the Breath Biopsy VOC Atlas® website. Such processing is covered by notices on the OMED Health website (https://omedhealth.com/privacy-policy/) and the OMED Health Mobile App, and www.vocatlas.com.
Throughout this document we refer to “Data Protection Legislation”, which means the Data Protection Act 2018 (DPA 2018), United Kingdom General Data Protection Regulation (UK GDPR), the Privacy and Electronic Communications (EC Directive) Regulations 2003 and any legislation implemented in connection with the aforementioned legislation. Where data is processed by a controller or processor established in the European Union or comprises the data of people in the European Union, it also includes the EU General Data Protection Regulation (EU GDPR). This includes any replacement legislation coming into effect from time to time.

DATA CONTROLLER

2. Data Controller

OML is the controller for the personal information we process as identified in this privacy notice. In some circumstances, OML will conduct clinical trials on behalf of other organisations. For the most part, the other organisation will be the controller in such circumstances and so you should refer to their privacy notices for details of how your data is processed.

Occasionally, OML will be a joint controller with one of our partner organisations. Where necessary or appropriate, such processing will be communicated to you in a separate privacy notice.
We are registered with the Information Commissioner’s Office (the ICO) with registration number ZB023504.

We have appointed a Data Protection Officer to help us monitor internal compliance, inform, and advise on data protection obligations, and act as a point of contact for data subjects and the ICO.
Our Data Protection Officer is:

The DPO Centre Ltd.
50 Liverpool Street
London
EC2M 7PY

We have also appointed an EU Representative to act on our behalf for EU GDPR matters.
Our EU Representative is The DPO Centre Europe Ltd.

For further details on how you can contact us or our EU Representative, please see the contact us section below.

INFORMATION WE COLLECT 

3. The information we collect and when

We only collect personal information that we know we will genuinely use and in accordance with the Data Protection Legislation. The type of personal information that we will collect on you depends on the nature of the relationship that we have with you. We may collect the following:

• Contact Data: Personal and business contact information (such as name, job title and employer name, email address, mailing address, phone number, and emergency contact information).
• Health Data: We collect health and medical information in connection with managing clinical trials and conducting research. This may include information about physical and mental health conditions and diagnoses, treatments for medical conditions, genetic information, family medical history, weight, height, diet, smoking status, alcohol intake, information relating to your breathing and collected breath samples, risk of exposure to or the presence of any infectious diseases, medications an individual may take, including the dosage, timing, and frequency, and other samples, which may include blood, urine, sputum, breath condensate, saliva or tissue.
• Analytical Data: Volatile organic compounds (i.e. molecules found on breath), derived data and metadata concerning, relating to, associated with or derived from the Health Data and Biographical Data.
• Biographical Data: Biographical and demographic information (such as date of birth, age, gender, and information regarding any parents or legal guardians).
• Website Data: Information collected through your use of our website, such as cookies and IP addresses. For more information, please see our Cookie Policy.
• Professional Data: Professional credentials, educational and professional history, and institutional affiliations.
• Investor Data: Where you are one of our investors, we have information on your investor profile information, and interactions.
• Communications Data: Your experiences, opinions, feedback or reviews on our products and services, and any other communications with us. For example, when you take part in usability testing.
• Transaction Data: Such as services used, and subscriptions, records of conversations, digital signature, and agreements and payment transactions.
• Marketing Data: Your preferences in receiving marketing from us, your communication preferences. This may extend to your photograph or social media handle, depending on how you interact with us.

Other information that we may collect that is not specifically listed here but that we will use in accordance with this privacy notice or as otherwise disclosed at the time of collection.

In most instances, you are under no statutory or contractual requirement or obligation to provide us with your personal information; however, we will often require elements of the information above in order to provide our services to you in an efficient and effective manner.

3.1. Children’s information

On occasion, children’s personal data may be processed in accordance with this privacy notice. The information in the relevant parts of this privacy notice therefore apply to children as well as adults in such instances.

We recognise that children require specific protection with regard to their personal data as they may be less aware of the risks, consequences and safeguards concerned and their rights in relation to the processing of personal data. Where we act as a controller for children’s data we will separately provide additional information for children to better understand data protection requirements.

INFORMATION USE

4. How we use your information

4.1 Collection

In most instances we collect personal information directly from you. In other instances, we may collect personal information from our website, public forums (e.g., social media), when you have or intend to attend an event to which we are affiliated, from contract research organisations, hospitals, healthcare professionals, academic or other research institutions, scientific journals, research data repositories (in some cases pseudonymised/aggregated or other cases anonymised data only and so on.

We may also collect your information from other studies or trials that you have previously or are currently participating in for use as part of our own medical research and scientific studies – please see section 4.6 below. Should this occur, you will be informed prior to you participation (where possible) in any such study and provided with our privacy information where required by Data Protection Legislation. Data from these studies will be pseudonymised so that you cannot be directly identified, and, to the extent practical, anonymised, so that you cannot be identified at all.

In other instances, one of our partner organisations may ask whether you would like to participate in a trial or usability testing with us. In these instances, should you confirm your interest, OML and our partner organisation will be independent controllers of your information. Any processing of your personal data by OML (excluding OMED Health) will be covered in this notice, or as part of other information provided to you.

4.2 Lawful basis

We only process, store or transfer your personal information when we have a legal basis for doing so. The legal basis we rely on to process the information identified in this notice are as follows:

• Legitimate Interest: processing is necessary for the purposes of our legitimate interests (i.e., our business interests or further scientific research), except where such interests are overridden by your interests or fundamental rights and freedoms.
• Consent: You have given consent to the processing of your personal data for one or more specific purposes. You may withdraw this consent at any time, either through the channel in which you provided your consent, or by getting in touch via the contact us section below.
• Legal obligation: processing is necessary for compliance with our legal obligations.
• Vital interests: processing is necessary in order to protect the vital interests of the data subject or of another natural person.
• Contractual obligation: processing is necessary for the performance of a contract to which you are a party or in order to take steps at your request prior to entering into a contract.

4.3 Purpose

We may use your data in accordance with the table below. Please note, for clinical trial processing, the lawful basis or details of the processing may differ depending on your jurisdiction. This will be made clear to you by the relevant party/(ies) in the documentation provided to you as part of and prior to commencing the clinical trial.

Processing activity	Data Category	Lawful basis
To contact you, following your enquiry, reply to any questions, suggestions, issues, or complaints you have contacted us about.	Contact Data, Communications Data	Legitimate Interest
To communicate with you and send B2B marketing communications, including where you have attended events or webinars. See also section 7 of this notice.	Contact Data, Communications Data, Marketing Data	Legitimate Interest
To determine whether you are eligible to take part in a clinical trial.	Biographical Data, Health Data, Contact Data	Legitimate Interest
To perform and administer clinical trials and research for our customers or with our collaboration partners.	Biographical Data, Health Data, Contact Data, Analytical Data	Legitimate Interest
To meet our high security standards in managing your personal data, our systems and our website.	All Data	Legitimate Interest
Where your data has been collected as part of a research study or clinical trial, we may further process the data for additional scientific or statistical research purposes (i.e., a secondary use of the data) where this is compatible with the primary purposes of collection. This may include adding your data to our scientific database. Please also see section 5 of this notice for more detail.	Health Data, Biographical Data, Analytical Data	Legitimate Interest
To run usability testing and use your experiences and feedback to improve our devices, products, and services.	Contact Data, Communications Data, Health Data	Legitimate Interest or Consent
To generate marketing/analytics from our website using cookies.	Website Data	Consent
To negotiate and/or enter into and/or fulfil a contract with you, or the organisation for which you work.	Contact Data, Professional Data, Transaction Data	Contractual Obligation or Legitimate Interest
To fulfil pre-contractual steps, such as supplier questionnaires, as part of our onboarding process.	Contact Data, Professional Data, Transaction Data	Contractual Obligation or Legitimate Interest
To comply with applicable laws, lawful requests, and legal process, where appropriate/necessary.	All Data depending on subject matter. We will only process the minimal data needed as part of any legal obligations	Legal Obligation (responding to legal claims)
To comply with regulatory monitoring and reporting obligations, where appropriate/necessary.	Contact Data, Biographical Data, Health Data
To share your data with healthcare professionals if you are taken ill or involved in an accident while visiting our office or sites, and are unable to provide your consent.	Contact Data, Biographical Data, Health Data	Vital Interest
Maintain our relationship and necessary records with investors.	Investor Data	Legitimate Interest Legal Obligation

4.4 Sensitive data

As well as the lawful bases identified above, when the data we are processing is considered ‘special category data’, such as your health information, we ensure that the processing is necessary for one of the following:

• Public interest in the area of public health, such as protecting against serious cross-border threats to health or ensuring high standards of quality and safety of health care and of medicinal products or medical devices.
• Archiving purposes in the public interest, scientific or historical research purposes or statistical purposes.  

In addition to the three lawful bases above, in limited circumstances, such as when you submit your health data for usability testing, we will process special category data based on your explicit consent. You may withdraw this consent at any time through the same channel by which you provided your consent, or by contacting our Data Privacy Team using the contact details below..

4.5 Anonymised data

In addition, we may create anonymous or aggregated data from your personal information and other individuals whose personal information we collect. We do this by excluding information that makes the data personally identifiable to you and use that anonymous data for research purposes.

SHARING INFORMATION 

5. Data for Scientific Research

We have developed and are continuing to grow and improve our methods, libraries and databases which are intended to help us achieve our mission to save lives and healthcare costs. These serve as scientific research resources for OML and (in some cases) authorised third-party researchers.

In particular, we see the Breath Biopsy VOC Atlas® (referred to as “Atlas”) as a natural extension of the trials and studies we participate in, in keeping with the Purpose Limitation principle under Data Protection Legislation and a way of making better use of the data provided to us or our partners by study participants such as you. We would like to thank all participants whose data forms part of Atlas in supporting us in our mission, and have added this section to our privacy notice to explain how we collect data, what form we collect it in and how we use it as part of Atlas.

5.1 The Breath Biopsy VOC Atlas®

Should you participate in a clinical trial or research study with us, or one of our clinical partners, the  data (excluding your name and date of birth) you provide for that trial or study and its results such as your age, disease history, chemical molecules on your breath together with other analytical and contextual information (“Atlas Data”) may be transferred to Atlas and used for further (secondary) research purposes. You will always be informed if this is the case and provided the opportunity to object to this additional processing. In some instances, you may be asked to consent to this data use, where appropriate. Whichever party is the controller of the initial trial will be responsible for providing the necessary information, opt-outs and/or consent forms in this regard. Once your data is transferred to Atlas, OML will be classed as an independent controller for the data held within it. This means that we will take on the primary responsibility under Data Protection Legislation for the control and protection your data in Atlas and for that particular purpose.

5.2 Data in atlas

Atlas will not be collecting any additional personal information to what has already been collected as part of the initial trial or research study that you have participated in with us or our partners. We have therefore broken down the data types as follows, which we believe will be of more use to you.

• Pseudonymised Data. All data held in Atlas is pseudonymised, which means you cannot be identified directly through Atlas alone. The pseudonymised data set will contain a subject ID and metadata in relation to the initial study that you took part in. Information regarding this data would have been provided to you when you signed up to participate in the original study, and could include age, cohort, disease history and treatment history.
• Identifiable Data. While identifiable data will not be held in Atlas directly, OML may hold some identifiable data for other purposes and in other databases (for example, if you are participating as a volunteer in an active trial or research study). This means that a very limited number of employees may be able to access some of your identifiable data (such as name and contact details) and your pseudonymised data. These individuals are prohibited from matching the data sets, unless there is genuine cause to (e.g. you make an erasure request). They are subject to strict confidentiality provisions and are required to undertake regular data security training.
• Anonymised Data. Where any Atlas data is shared with clinical partners, researchers or corporate affiliates, it is strictly anonymised or aggregated, so that the data cannot be linked back to you by any third parties. Any such recipients will be subject to acceptable use agreements regarding the data.
• Generated Data. We may generate further data to enhance our database based on the data that we already hold on you in Atlas. This includes, by way of example, biomarkers – which include common biomarkers, such as cholesterol, infectious disease markers, proteomic and metabolomic markers – and genetic data (ranging from genotype to exome sequence to whole genome sequence). For such activities, participants will always remain pseudonymised or anonymised, as relevant.

5.2 Data use in Atlas

Our lawful basis for Atlas does not differ from our usual lawful bases for clinical trials – i.e. we largely rely on legitimate interest to process data for Atlas and the scientific research exception for processing your health (i.e. special category) data. We consider Atlas a “secondary research purpose” compatible with the purpose for which the initial trials were carried out. Depending on your jurisdiction or relationship with OML, we may rely on consent for the processing of your personal data. You may withdraw this consent at any time, either through the channel in which you provided your consent, or by getting in touch via the contact us section below.

Data in Atlas will be used as follows:

Processing activity	Data Processed	Lawful basis
To assess data from multiple clinical studies in order to better interpret the results and provide greater understanding of VOC capability, ranges and variabilities.	Pseudonymised and Generated Data as described in 5.2.	Legitimate Interest (secondary research) or Consent Scientific Research Purposes
To share Atlas Data with our clinical or research partners so that they can improve the statistical relevance of their own studies (e.g. if a partner has limited subjects taking part in their study).	Anonymised Data	Legitimate Interest (secondary research) or Consent Scientific Research Purposes
To share Atlas Data with academic researchers, clinicians, students and post-doctoral researchers, charities and government departments that carry out significant research, who have registered with Owlstone to access Atlas Data using an online platform, in order to aid the global research community in making discoveries for the benefit of the public health at large.	Anonymised Data	Legitimate Interest (secondary research) Scientific Research Purposes
To compare findings from one study with the general Atlas population to better evaluate findings, identify trends, etc.	Pseudonymised Data internally, Anonymised data for any sharing.	Legitimate Interest (secondary research) or Consent Scientific Research Purposes
To facilitate your rights and withdrawals regarding Atlas, or otherwise communicate with you.	Identifiable Data	Legitimate Interest (to response and communicate with you)

All Atlas Data is stored in secure third-party, UK-based, cloud data centres or servers. Certain Atlas Data may be published on the Atlas website (www.vocatlas.com) strictly for research purposes. Any such users of the Atlas website with access to Atlas Data will not have access to any identifiable information.

Data held in Atlas is stored for archiving, research and statistical purposes. OML therefore retains data in Atlas for as long as it has a legitimate interest in doing so – but has set an initial retention period of 10 years from the date of transfer to Atlas. Retention will be under periodic review and consideration as to its value and need to extended retention. OML has appropriate safeguards in place to protect your data held in Atlas.

Should you object to the processing (or withdraw your consent where valid), we will cease processing your data as part of Atlas. Please note, if you object (or withdraw consent) to OML processing your data as part of Atlas, your data may still be processed as part of the initial trial that you signed up to and will be managed in accordance with documentation you were provided with upon sign up to that trial.

There is no expectation for data in Atlas to be transferred outside of the UK or the EEA to countries not deemed by the ICO (and/or European Commission as relevant) to provide an adequate level of personal information protection. Should this be required in the future, the transfer will be based on safeguards that allow us to conduct the transfer in accordance with the data protection legislation, as detailed in section 7 of this notice.

The other sections of this privacy notice (excluding section 4) apply to this section 5, however, where there are conflicts between section 5 and other sections, the provisions in section 5 apply.

6. Who we might share your information with

We may share your personal data with trusted third-party organisations, subject to written agreements, as follows:

• With business partners and corporate affiliates to support our services, as outlined in this notice.
• With third party companies or individuals (data processors) to perform services on our behalf. This could include contract research organisations; data storage and analytics companies; technology support and services (email, web hosting, marketing, and advertising providers, etc.).

We only share your data with data processors that can provide sufficient guarantees that they will process your data securely and in accordance with Data Protection Legislation. Our data processors are not legally permitted to do anything with your personal information unless we have instructed them to do it. They have provided us with written agreements that they will not share your personal information with any organisation apart from us or further sub-processors (supporting an aspect of the same service, study, trial or otherwise) which must process your personal to the same high standards.

• With partners with whom we jointly process your data.

• With health care professionals, researchers, academics, students and post-doctoral researchers, public health organisations, charities and government departments that carry out significant research, and publishers for purposes consistent with this privacy notice (particularly section 5.3 above).
• With professional advisors, such as lawyers, bankers, auditors, and insurers, where necessary in the course of the professional services that they render to us.
• With government or law enforcement officials or private parties as required by law and disclose and use such information as we believe necessary or appropriate.

In some situations, we may have a separate agreement or relationship with you with respect to a specific type of processing of your data, such as if you participate in a clinical trial. These situations will be governed by specific terms, privacy notices, or consent forms that provide additional information about how we will use your information.  We will honour these additional terms with respect to your information and thus, strongly recommend you review the additional terms prior to participating.

6.1 Open Access for the Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation supports OML in its goals to develop new cost-effective  technologies and platforms  to detect VOCs that could serve as markers of diseases that disproportionately affect the developing world.

As part of this support, OML seeks to comply with The Bill & Melinda Gates Foundation’s Open Access Policy. This enables the Foundation and other researchers to have unrestricted access and reuse of all peer-reviewed published research funded in whole or in part, by the Foundation, including any data underlying published research results (in compliance with any ethical or legal requirements).

OML will never share identifiable information about any of those who participate in its research and strict measures are in place to ensure that the privacy of research participants is protected, taking into account access rights and ethical considerations. OML has further entered into a contractual agreement to ensure privacy is upheld and any international transfers of data covered, where necessary.

For more information on our partnership with the Foundation, please click here. Owlstone Lands $6.5M for Breath-based Infectious Disease Diagnostics (owlstonemedical.com)

For more information on the Open Access Policy, please click here. Open Access Policy | Bill & Melinda Gates Foundation

INTERNATIONAL INFORMATION TRANSFERS

7. International transfers of information

Other than where OML runs its own research study and collects breath samples in the UK, all breath samples and associated data relating to the data subjects originate in the place of sample collection.  Therefore, in most cases it is the relevant partner, hospital, academic or research institution that will transfer the samples and associated data from their location (this could be anywhere in the world) to OML for analysis. When OML reports on the results of that analysis, this involves “returning” the data originally received back to its location.

Data is deemed to have been transferred when (a) OML deposits its research results (including underlying scientific data) into a research data repository which can be accessed from outside the UK, or (b) it allows user access to Atlas Data. However, as set out in this privacy notice, it will not be possible to identify you from the data made available under (a) or (b).

Whenever we transfer your personal information outside of the UK to countries not deemed by the ICO (and/or European Commission as relevant) to provide an adequate level of personal information protection, the transfer will be based on safeguards that allow us to conduct the transfer in accordance with the data protection legislation, such as the specific contracts approved by the ICO (or European Commission as relevant) providing adequate protection of personal information. 

KEEPING YOU UPDATED 

8. How we keep you updated on our services

As a business contact, we will send you relevant news about our services or products in a number of ways including by email, but only if we have a legitimate interest to do so. Marketing communications will be sent from our own domain.

Each email communication will have an option to object to the processing, if you wish to amend your marketing preferences, you can do so by following the link in the email and updating your preferences or by calling us on the number displayed on our website.

We make every effort to ensure that we only send such communications to those acting in a business capacity and do not send such materials to consumers via personal email addresses if it is clear they are not acting in such a capacity.

YOUR RIGHTS 

9. Your rights over your information

9.1 The right to be informed about our collection and use of personal data

You have the right to be informed about the collection and use of your personal data. We ensure we do this with our internal data protection policies and through this and other privacy notices. These are regularly reviewed and updated to ensure these are accurate and reflect our data processing activities..

9.2 Right to access your personal information

You have the right to access the personal information that we hold about you in many circumstances, by making a request. This is referred to as a ‘Data Subject Access Request’. If we agree that we are obliged to provide personal information to you (or someone else on your behalf), we will provide it to you or them free of charge and aim to do so within one month from when your identity has been confirmed.

We would ask for proof of identity and sufficient information about your interactions with us that we can locate your personal information.

If you would like to exercise this right, please contact us as set out below.

9.3 Right to rectify your personal information

If any of the personal information we hold about you is inaccurate, incomplete, or out of date, you may ask us to correct it.

If you would like to exercise this right, please contact us as set out below.

9.4 Right to object or restrict our processing of your data

You have the right to object to us processing your personal information for particular purposes or have its processing restricted in certain circumstances.

If you would like to exercise this right, please contact us as set out below.

9.5 Right to erasure

You have the right to have personal data erased. This is also known as the ‘right to be forgotten’. The right is not absolute and only applies in certain circumstances.

If you would like to exercise this right, please contact us as set out below.

9.6 Right to portability

The right to portability gives you the right to receive personal data you have provided to a controller in a structured, commonly used, and machine-readable format. It also gives them you the right to request that a controller transmits this data directly to another controller.

This right is unlikely to apply to OML’s use of your data, but if you would like to discuss this right, please contact us as set out below.

9.7 For more information about your privacy rights

The Information Commissioner’s Office (ICO) regulates data protection and privacy matters in the UK. They make a lot of information accessible to consumers on their website and they ensure that the registered details of all data controllers such as ourselves are available publicly. You can access them here https://ico.org.uk/for-the-public.

You can make a complaint to the ICO at any time about the way we use your information. However, we hope that you would consider raising any issue or complaint you have with us first. Your satisfaction is extremely important to us, and we will always do our very best to solve any problems you may have.

INFORMATION RETENTION 

10. How long we keep your information for

We will retain your personal information in order to provide you with a high-quality service, in accordance with Data Protection Legislation and for as long as necessary to fulfil the purposes we collected it for, including for the purposes of satisfying any legal, accounting, or reporting requirements.

To determine the appropriate retention period for personal information, we consider the amount, nature, and sensitivity of the personal information, the potential risk of harm from unauthorised use or disclosure of your personal information, the purposes for which we process your personal information and whether we can achieve those purposes through other means.

In some circumstances we may anonymise your personal information (so that it can no longer be associated with you).

YOUR REVIEWS AND OPINIONS 

11. Giving your reviews and sharing your thoughts

When using our websites, you may be able to share information through social networks like Facebook and Twitter. For example, when you ‘like’, ‘share’ or review our Services. When doing this, your personal information may be visible to the providers of those social networks and/or their other users. Please remember it is your responsibility to set appropriate privacy settings on your social network accounts, so you are comfortable with how your information is used and shared on them.

SECURITY 

12. Security

Data security is of great importance to OML and to protect your data we have put in place suitable physical, electronic, and managerial procedures to safeguard and secure your collected data. 

We take security measures to protect your information including:

• Limiting access to our buildings to those that we have determined are entitled to be there (by use of passes, key card access and other related technologies).
• Implementing access controls to our information technology.
• We use appropriate procedures and technical security measures (including pseudonymisation, strict encryption and archiving techniques) to safeguard your information across all our computer systems, networks, websites, mobile apps, and offices.

IF WE CHANGE HANDS 

13. What happens if our business changes hands?

We may, from time to time, expand or reduce our business and this may involve the sale and/or the transfer of control of all or part of our business. Any personal data that you have provided will, where it is relevant to any part of our business that is being transferred, be transferred along with that part and the new owner or newly controlling party will, under the terms of this privacy notice, be permitted to use that data only for the purposes for which it was originally collected by us.

POLICY CHANGES 

14. Changes to Our Privacy Notice

We may change this privacy notice from time to time (for example, if the law changes). We recommend that you check this notice regularly to keep up to date.

CONTACT US 

15. How to contact us

For general enquiries please use our contact form.

If you would like to exercise one of your rights as set out above, or you have a question or a complaint about this notice, or the way your personal information is processed, please contact us by one of the following means:

By email: privacy@owlstone.co.uk
By post: Owlstone Medical Limited, 183, Cambridge Science Park, Milton Road, Milton, Cambridge, CB4 0GJ
By phone: 01223 428200

If you are based in Europe, you can contact our EU Representative, The DPO Centre Europe Ltd: By email: EuRep@owlstone.co.uk 
By post: The DPO Centre Ltd, Rue des Poissonniers 13, 1000 Brussels, Belgium
By phone: +32 2 786 19 61

Thank you for taking the time to read our privacy notice.

This notice was last updated in September 2024.